Clinical Trial Update: Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety, efficacy, and tolerability of Paliperidone Extended-Release in adults with schizophrenia; the study completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone Extended-Release (ER) (Paliperidone)

Snippet

Sponsor: Janssen Pharmaceutica | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2014-03-26